Antiretroviral Protease Inhibitors Market Trends

Growth Driver

Increasing Appeal of Protease Inhibitor to Boost Market Growth

Protease inhibitors are being used in various fields now-a-days. They are used in research for clinical application, drugs for treatment of diseases such as HIV/AIDS and Hepatitis C and others. On the back of this increasing product appeal anti-retroviral protease inhibitors are anticipated to fuel the market growth in the forecast period.

High Prevalence of HIV and HCV to Drive Market Growth

Anti-retroviral protease inhibitors are major drugs in the treatment of diseases such as HIV and HCV. With the increasing number of cases coupled with high prevalence of these diseases the demand for these drugs are bound to increase as well. Thereby, it is anticipated that the market for antiretroviral protease inhibitor will show significant CAGR over the forecast period.

Challenges

Side Effects of Drugs to Hamper Growth

Anti-retroviral protease inhibitors have side effects and unbearable toxicity and hence people hesitate in using these drugs. So there is a challenge in-front of drug manufacturing companies to innovate and prepare drug which have either no side effects or they have only a few non-severe side effects.

Stringent Regulation Environment to Hamper Market Growth

In an effort to protect public from harmful drug effects, governments make rule and regulations stringent. Usually government regulations make product development more expensive. Such environment can create a hindrance in the market growth in that region.

Time Consuming Approval Process of Drugs to Restrain Market Growth

From the time of research and development to the official launch of drugs, it takes a very long time. Even after development and successful trials, approval from regulatory authority takes a lot of time and a lot of entrepreneurs and big players do not invest in drug manufacturing due to this reason. Over the forecast period this may hamper the growth of injectable drug for type 2 diabetes market.